Genetic diagnosis for drug resistance in cancers

T. Funato, S. Fujimaki, J. Fujiwara, T. Miura, K. Yoshida, M. Kaku, T. Sasaki

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

The failure of chemotherapy to eradicate tumor cells is often due to the development of drug resistance. MDR(multidrug resistance) whose one form of resistance results from a decreased intracellular accumulation of the drugs, most often mediated by the overexpression of P-glycoprotein. MRP also related to pump function of cell membrane in acute leukemia. We have developed the new quantitative assay based on real-time PCR to measure expression of drug-resistance related genes such as MDR-1 and MRP in clinical samples. These results indicates that real-time PCR system is a reliable method to quantitatively determine drug resistant genes expression, it may be to predict responsiveness to chemotherapy by using this technique.

Original languageEnglish
Pages (from-to)162-166
Number of pages5
JournalRinsho byori. The Japanese journal of clinical pathology
Volume48
Issue number2
Publication statusPublished - 2000 Feb

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Genetic diagnosis for drug resistance in cancers'. Together they form a unique fingerprint.

Cite this